CompanyGraph
At a glance
- Depends onDownstream position: depends on 11 industries, supplies 6
- ScaleRevenue is $5.12B, above the global median of $562.3M
- FinancialsAltman Z-Score 2.96: safe zone
- Interpretations1 currently firing — 1
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
3.62%Above 5Y avg (1.40%)
Annual Rate
CNY 0.35Paid annual
Payout Ratio
0.0%Sustainable
Payback Period
28.1 yr
Last Ex-Dividend
Jul 10, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
5.52BCNY825.36M · vs all stocks (USD)
Trailing P/E
11.77xRevenue (TTM)
34.20BCNY5.12B · vs all stocks (USD)
Profit Margin
1.31%Beta
0.2160xvs all stocks
52-Week Change
-13.46%vs all stocks
Market Capitalization
5.52BCNY825.36M · vs all stocks (USD)
Enterprise Value
8.74BCNY1.31B · vs all stocks (USD)
Trailing P/E
11.77xPrice to Sales (TTM)
0.1613xPrice to Book (MRQ)
0.9999xEnterprise to Revenue
0.2560xEnterprise to EBITDA
9.32xGross Margin
6.33%Profit Margin
1.31%Operating Margin
2.54%Return on Assets (TTM)
3.17%Return on Equity (TTM)
9.72%Revenue (TTM)
34.20BCNY5.12B · vs all stocks (USD)
Revenue per Share (TTM)
63.09CNYUpdated Oct 18, 2026Quarterly Revenue Growth
4.50%Gross Profit (TTM)
2.40BCNY358.40M · vs all stocks (USD)
EBITDA (TTM)
977.08MCNY146.13M · vs all stocks (USD)
Net Income (TTM)
447.92MCNY66.99M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-22.10%Operating Cash Flow (TTM)
759.18MCNY113.54M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
189.14MCNY28.29M · vs all stocks (USD)
Trailing Annual Dividend Rate
0.3540CNYUpdated Oct 18, 2026Trailing Annual Dividend Yield
3.62%vs all stocks
5-Year Average Dividend Yield
1.40%vs all stocks
Payout Ratio
0.00%Minority Interest (Equity)
676.22MCNYFY2025 · Dec 31, 2025Revenue
33.68BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
31.32BCNYFY2025 · Dec 31, 2025Gross Profit
2.36BCNYFY2025 · Dec 31, 2025Operating Income
999.28MCNY149.45M · vs all stocks (USD)
Pre-tax Income
816.70MCNYFY2025 · Dec 31, 2025Income Tax Expense
212.69MCNYFY2025 · Dec 31, 2025Net Income
604.01MCNYFY2025 · Dec 31, 2025EBIT
984.74MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
1.20BCNYFY2025 · Dec 31, 2025Research & Development
20.33MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
613.53MCNYFY2025 · Dec 31, 2025Other Operating Expenses
88.31MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
25.88MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
168.04MCNYFY2025 · Dec 31, 2025EPS (Basic)
0.9600CNYFY2025 · Dec 31, 2025EPS (Diluted)
0.9400CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
522.12MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
522.12MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
604.01MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
-102.77MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
-231.79MCNYFY2025 · Dec 31, 2025Free Cash Flow
-468.13MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
1.51BCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
604.01MCNYFY2025 · Dec 31, 2025Other Non-cash Items
179.38MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-669.80MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-345.39MCNYFY2025 · Dec 31, 2025Capital Expenditures
-236.34MCNYFY2025 · Dec 31, 2025Net Acquisitions
-441.85MCNYFY2025 · Dec 31, 2025Purchase of Investments
-96.20MCNYFY2025 · Dec 31, 2025Sale of Investments
106.36MCNYFY2025 · Dec 31, 2025Other Investing Activity
-7.02MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-675.05MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
7.68BCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-6.40BCNYFY2025 · Dec 31, 2025Common Dividends Paid
-329.80MCNYFY2025 · Dec 31, 2025Other Financing Charges
-345.63MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
597.21MCNYFY2025 · Dec 31, 2025Shares Outstanding
564.85MSharesUpdated Oct 18, 2026Float Shares
173.47MSharesUpdated Oct 18, 2026% Held by Insiders
70.14%vs all stocks
% Held by Institutions
0.40%vs all stocks
Total Cash (MRQ)
1.96BCNY292.44M · vs all stocks (USD)
Total Cash per Share (MRQ)
3.46CNYUpdated Oct 18, 2026Total Debt (MRQ)
4.48BCNY670.10M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.7206xCurrent Ratio (MRQ)
1.38xBook Value per Share (MRQ)
9.77CNYUpdated Oct 18, 2026Total Assets
16.78BCNY2.51B · vs all stocks (USD)
Total Current Assets
14.34BCNYFY2025 · Dec 31, 2025Total Liabilities
11.00BCNYFY2025 · Dec 31, 2025Total Non-current Assets
2.44BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
490.95MCNYFY2025 · Dec 31, 2025Total Current Liabilities
10.51BCNYFY2025 · Dec 31, 2025Cash
1.50BCNYFY2025 · Dec 31, 2025Cash Equivalents
438.52MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
1.94BCNYFY2025 · Dec 31, 2025Accounts Receivable
7.31BCNYFY2025 · Dec 31, 2025Inventory
4.29BCNYFY2025 · Dec 31, 2025Accounts Payable
6.04BCNYFY2025 · Dec 31, 2025Short-term Debt
3.02BCNYFY2025 · Dec 31, 2025Other Current Liabilities
621.87MCNYFY2025 · Dec 31, 2025Long-term Debt
384.84MCNYFY2025 · Dec 31, 2025Common Stock (Book)
540.78MCNYFY2025 · Dec 31, 2025Retained Earnings
2.27BCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
5.78BCNY864.57M · vs all stocks (USD)
Treasury Stock
1.66MCNYFY2025 · Dec 31, 202552-Week Low
8.62CNYUpdated Oct 18, 202652-Week High
14.36CNYUpdated Oct 18, 202652-Week Change
-13.46%vs all stocks
Beta
0.2160xvs all stocks
50-Day MA
9.97CNYUpdated Oct 18, 2026200-Day MA
10.84CNYUpdated Oct 18, 2026Avg 10-Day Volume
4.17MSharesUpdated Oct 18, 2026Avg 30-Day Volume
4.03MSharesUpdated Oct 18, 2026Diluted EPS (TTM)
0.8300CNYUpdated Oct 18, 20261 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company growing?
Multi-Year Revenue, Profit, And Income Growth
Revenue has risen in each of three years, gross profit in each of four, and it has made a profit in all five.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 2.96: safe zoneNotable
Altman Z-Score: 2.96
Supply Chain
Downstream position: depends on 11 industries, supplies 6Notable
Outgoing: 6.00Incoming: 11.00
High connectivity hub: 17 industry connectionsNotable
Total Connections: 17.00
Scale
Revenue is $5.12B, above the global median of $562.3MNotable
Revenue (USD): 5,115,448,893.358Global Median: 562,304,852.367
Levered free cash flow is $28.29M, above the global median of $18.69MNotable
Levered free cash flow (USD): 28,288,505.86Global Median: 18,689,872.41
Companies that share the same coordination system — how they create, deliver, or capture value.
Hainan Haiyao Co. Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Wuhan Keqian Biology Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Oxford Biomedica plc
Tier 1ProductionApproval-Gated PipelineFlowRule
Genomma Lab Internacional S.A.B. de C.V.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Youcare Pharmaceutical Group Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Hangzhou Biotest Biotech Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Tong Ren Tang Technologies Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Vireo Growth Inc.
Tier 1ProductionApproval-Gated PipelineFlowInterface
China Isotope & Radiation Corporation
Tier 1ProductionApproval-Gated PipelineRuleFlow
Hpgc Renmintongtai Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Companies that share active interpretations — structural patterns currently present in both stocks.
Hyosung Heavy Industries Corporation
1 interpretationMulti-Year Revenue, Profit, And Income Growth
Henan Lingrui Pharmaceutical Co., Ltd.
1 interpretationMulti-Year Revenue, Profit, And Income Growth
Zhongjin Gold Corp.
1 interpretationMulti-Year Revenue, Profit, And Income Growth